Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

National Healthcare (NHC) EBITDA (2016 - 2025)

National Healthcare (NHC) has disclosed EBITDA for 16 consecutive years, with $33.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 14.55% year-over-year to $33.1 million, compared with a TTM value of $128.4 million through Dec 2025, up 42.78%, and an annual FY2025 reading of $128.4 million, up 42.78% over the prior year.
  • EBITDA was $33.1 million for Q4 2025 at National Healthcare, up from $30.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $34.1 million in Q2 2025 and bottomed at $4.1 million in Q3 2022.
  • Average EBITDA over 5 years is $17.9 million, with a median of $14.7 million recorded in 2021.
  • The sharpest move saw EBITDA plummeted 68.05% in 2022, then skyrocketed 219.4% in 2023.
  • Year by year, EBITDA stood at $9.1 million in 2021, then decreased by 1.05% to $9.0 million in 2022, then surged by 125.9% to $20.4 million in 2023, then soared by 41.42% to $28.9 million in 2024, then grew by 14.55% to $33.1 million in 2025.
  • Business Quant data shows EBITDA for NHC at $33.1 million in Q4 2025, $30.4 million in Q3 2025, and $34.1 million in Q2 2025.